UBS AM’s Rocket Pharmaceuticals RCKT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$934 Buy
261
+169
+184% +$672 ﹤0.01% 3686
2025
Q4
$323 Sell
92
-21,830
-100% -$74.7K ﹤0.01% 3254
2025
Q3
$71.5K Sell
21,922
-264,390
-92% -$833K ﹤0.01% 2233
2025
Q2
$701K Buy
286,312
+101,620
+55% +$515K ﹤0.01% 2450
2025
Q1
$1.23M Buy
184,692
+45,120
+32% +$446K ﹤0.01% 2220
2024
Q4
$1.75M Buy
139,572
+19,939
+17% +$300K ﹤0.01% 2116
2024
Q3
$2.21M Buy
119,633
+1,561
+1% +$32K ﹤0.01% 1986
2024
Q2
$2.54M Buy
118,072
+52,282
+79% +$1.2M ﹤0.01% 1869
2024
Q1
$1.77M Sell
65,790
-5,221
-7% -$148K ﹤0.01% 1745
2023
Q4
$2.13M Buy
71,011
+20,841
+42% +$460K ﹤0.01% 1662
2023
Q3
$1.03M Buy
50,170
+18,499
+58% +$336K ﹤0.01% 1946
2023
Q2
$543K Hold
31,671
﹤0.01% 2287
2023
Q1
$543K Sell
31,671
-21,800
-41% -$427K ﹤0.01% 2287
2022
Q4
$1.05M Buy
53,471
+14,333
+37% +$264K ﹤0.01% 1831
2022
Q3
$625K Hold
39,138
﹤0.01% 2241
2022
Q2
$539K Hold
39,138
﹤0.01% 2276
2022
Q1
$621K Hold
39,138
﹤0.01% 2377
2021
Q4
$854K Sell
39,138
-8,342
-18% -$228K ﹤0.01% 2298
2021
Q3
$1.42M Sell
47,480
-1,372
-3% -$49.9K ﹤0.01% 1991
2021
Q2
$2.16M Buy
48,852
+11,512
+31% +$500K ﹤0.01% 1806
2021
Q1
$1.66M Buy
37,340
+1,869
+5% +$103K ﹤0.01% 1835
2020
Q4
$1.95M Hold
35,471
﹤0.01% 1698
2020
Q3
$811K Buy
35,471
+4,080
+13% +$101K ﹤0.01% 1925
2020
Q2
$657K Buy
+31,391
New +$566K ﹤0.01% 1995
2020
Q1
Sell
-9,414
Closed -$214K 2519
2019
Q4
$214K Buy
+9,414
New +$157K ﹤0.01% 2462
2019
Q3
Sell
-12,438
Closed -$187K 2898
2019
Q2
$187K Buy
+12,438
New +$217K ﹤0.01% 2558

Other funds holding RCKT